Folyóiratcikkek tallózása cím szerint

A találatok rendezése: Rendezés: Találatok:

  • Risk of infection and prevention in pediatric patients with IBD: ESPGHAN IBD Porto group commentary 
    Veereman-Wauters G; De Ridder L; Veres, Gábor; Kolacek S; Fell J; Malmborg P; Koletzko S; Dias JA; Misak Z; Rahier J-F; Escher JC; ESPGHAN IBD Porto Group (2012)
    Combined immunosuppression by immunomodulators and biological therapy has become standard in the medical management of moderate-tosevere inflammatory bowel disease (IBD) because of clearly demonstrated efficacy. Clinical ...
  • Risk of Soft-Tissue Sarcoma Among 69 460 Five-Year Survivors of Childhood Cancer in Europe 
    Bright, CJ; Hawkins, MM; Winter, DL; Alessi, D; Allodji, RS; Bagnasco, F; Bárdi, Edit; Bautz, A; Byrne, J; Feijen, EAM; Fidler, MM; Garwicz, S; Grabow, D; Gudmundsdottir, T; Guha, J; Haddy, N; Jankovic, M; Kaatsch, P; Kaiser, M; Kuehni, CE; Linge, H; Ofstaas, H; Ronckers, CM; Skinner, R; Teepen, JC; Terenziani, M; Vu-Bezin, G; Wesenberg, F; Wiebe, T; Sacerdote, C; Jakab, Zsuzsanna; Haupt, R; Lahteenmaki, P; Zaletel, LZ; Kuonen, R; Winther, JF; de Vathaire, F; Kremer, LC; Hjorth, L; Reulen, RC; PanCareSurFup Consortium (2018)
    Background: Childhood cancer survivors are at risk of subsequent primary soft-tissue sarcomas (STS), but the risks of specific STS histological subtypes are unknown. We quantified the risk of STS histological subtypes after ...
  • Risk of subsequent primary leukaemias among 69,460 five-year survivors of childhood cancer diagnosed from 1940 to 2008 in Europe 
    Allodji, Rodrigue S; Hawkins, Mike M; Bright, Chloe J; Fidler-Benaoudia, Miranda M; Winter, David L; Alessi, Daniela; Fresneau, Brice; Journy, Neige; Morsellino, Vera; Bárdi, Edit; Bautz, Andrea; Byrne, Julianne; Feijen, Elizabeth Lieke Am; Teepen, Jop C; Vu-Bezin, Giao; Rubino, Carole; Garwicz, Stanislaw; Grabow, Desiree; Gudmundsdottir, Thorgerdur; Guha, Joyeeta; Hau, Eva-Maria; Jankovic, Momcilo; Kaatsch, Peter; Kaiser, Melanie; Linge, Helena; Muraca, Monica; Llanas, Damien; Veres, Cristina; Øfstaas, Hilde; Diallo, Ibrahima; Mansouri, Imene; Ronckers, Cecile M; Skinner, Roderick; Terenziani, Monica; Wesenberg, Finn; Wiebe, Thomas; Sacerdote, Carlotta; Jakab, Zsuzsanna; Haupt, Riccardo; Lähteenmäki, Päivi; Zaletel, Lorna Zadravec; Kuehni, Claudia E; Winther, Jeanette F; Michel, Gisela; Kremer, Leontien CM; Hjorth, Lars; Haddy, Nadia; de Vathaire, Florent; Reulen, Raoul C (2019)
    Survivors of childhood cancers are at risk of developing subsequent primary leukaemias (SPLs), but the long-term risks beyond 20 years of treatment are still unclear. We investigated the risk of SPLs in five-year childhood ...
  • Risk of subsequent primary oral cancer in a cohort of 69,460 5-year survivors of childhood and adolescent cancer in Europe: the PanCareSurFup study 
    Sunguc, C.; Hawkins, M.M.; Winter, D.L.; Dudley, I.M.; Heymer, E.J.; Teepen, J.C.; Allodji, R.S.; Belle, F.N.; Bagnasco, F.; Byrne, J.; Bárdi, E.; Ronckers, C.M.; Haddy, N.; Gudmundsdottir, T.; Garwicz, S.; Jankovic, M.; van, der Pal H.J.H.; Mazić, M.Č.; Schindera, C.; Grabow, D.; Maule, M.M.; Kaatsch, P.; Kaiser, M.; Fresneau, B.; Michel, G.; Skinner, R.; Wiebe, T.; Sacerdote, C.; Jakab, Zsuzsanna; Gunnes, M.W.; Terenziani, M.; Winther, J.F.; Lähteenmäki, P.M.; Zaletel, L.Z.; Kuehni, C.E.; Kremer, L.C.; Haupt, R.; de, Vathaire F.; Hjorth, L.; Reulen, R.C. (2023)
  • Risk of Subsequent Primary Tumor Development in Melanoma Patients 
    Tóth Veronika; Hatvani Zsófia; Somlai Beáta; Hársing Judit; László János F; Kárpáti Sarolta (2013)
    Incidence of subsequent malignant tumor development in 740 patients with primary cutaneous melanoma verified between 2006 and 2010 at the Semmelweis University was studied retrospectively and was compared to data of sex ...
  • Ritkábban előforduló, alsó légúti fertőzést okozó Gram-negatív nem fermentáló pálcák 
    Juhász, Emese; Iván, Miklós Ábel; Pongrácz, Júlia; Kristóf, Katalin (2018)
  • Ritka bélfejlődési rendellenesség: colonatresia 
    Várkonyi, Ildikó; Kiss, Imre; Kálmán, Attila; Kis, Éva (2013)
  • Ritka etiológiájú Cushing-szindróma. 
    Sohar G,; Szücs, Nikolette; Rácz, Károly; Merkely, Béla Péter; Hüttl, Kálmán; Sármán, Pál; Gasztonyi, Beáta (2013)
    The authors present the case history of a 74-year-old male suffering from aortic coarctation. His endocrine evaluation was initiated because of severe hypokalemia. The diagnostic procedures revealed the presence of Cushing's ...
  • Ritka idegrendszeri betegségek kezelésére szolgáló gyógyszerek támogatása. Árva gyógyszerek ritka neurológiai kórképekben 
    Szegedi Márta; Kosztolányi György; Boncz Imre; Molnár Mária Judit (2016)
    Objectives – Nervous system involvement is expected up to 60-70% in case of rare diseases. This article aims to present the financial methods and expenditures of rare neurological diseases’ orphan medicinal products being ...
  • Ritka örökletes anyagcsere-betegségek diagnosztikája 
    Szabó, Eszter; Balogh, Lídia; Szabó, Attila; Szatmári, Ildikó (2017)
  • Egy ritka, veleszületett neurodegeneratív betegség: a cerebrotendinosus xanthomatosis laboratóriumi diagnosztikája 
    Varga Viktória Evelin; Katkó Mónika; Harangi János; Balogh István; Kapás István; Madar László; Seres Ildikó; Molnár Mária Judit; Paragh György; Kovács G. Gábor; Harangi Mariann (2014)
    Cerebrotendinous xanthomatosis is a rare neurodegenerative disease characterized by the accumulation of cholesterol and cholestanol in the brain and the tendons caused by mutations of the gene encoding sterol 27-hydroxylase ...
  • Rituximab for High-Risk, Mature B-Cell Non-Hodgkin’s Lymphoma in Children 
    Minard-Colin, Véronique; Aupérin, Anne; Pillon, Marta; Burke, GA Amos; Barkauskas, Donald A; Wheatley, Keith; Delgado, Rafael F; Alexander, Sarah; Uyttebroeck, Anne; Bollard, Catherine M; Zsiros, József; Csóka, Monika; Kazanowska, Bernarda; Chiang, Alan K; Miles, Rodney R; Wotherspoon, Andrew; Adamson, Peter C; Vassal, Gilles; Patte, Catherine; Gross, Thomas G (2020)
  • Rivaroxabankezelés mellett kialakult bal pitvari fülcsethrombus sikeres kezelése direkt trombininhibitorral 
    Szegedi, Nándor; Gellér, László Alajos; Tahin, Tamás; Merkely, Béla Péter; Széplaki, Gábor (2016)
    The authors present the history of a 62-year-old man on continuous rivaroxaban therapy who was scheduled for pulmonary vein isolation due to persistent atrial fibrillation. Preoperative transesophageal echocardiography ...
  • Rizedronát: gyors hatás a törési kockázat csökkentésében 
    Szathmári, Miklós (2003)
  • ROAMER: roadmap for mental health research in Europe. 
    Haro JM; Ayuso-Mateos JL; Bitter, István; Demotes-Mainard J; Leboyer M; Lewis SW; Linszen D; Maj M; McDaid D; Meyer-Lindenberg A; Robbins TW; Schumann G; Thornicroft G; Van Der Feltz-Cornelis C; Van Os J; Wahlbeck K; Wittchen HU; Wykes T; Arango C; Bickenbach J; Brunn M; Cammarata P; Chevreul K; Evans-Lacko S; Finocchiaro C; Fiorillo A; Forsman AK; Hazo JB; Knappe S; Kuepper R; Luciano M; Miret M; Obradors-Tarrago C; Pagano G; Papp, Szilvia; Walker-Tilley T (2014)
    Despite the high impact of mental disorders in society, European mental health research is at a critical situation with a relatively low level of funding, and few advances been achieved during the last decade. The development ...
  • Robustness and applicability of transcription factor and pathway analysis tools on single-cell RNA-seq data 
    Holland, Christian H; Tanevski, Jovan; Perales-Patón, Javier; Gleixner, Jan; Kumar, Manu P; Mereu, Elisabetta; Joughin, Brian A; Stegle, Oliver; Lauffenburger, Douglas A; Heyn, Holger; Szalai, Bence; Saez-Rodriguez, Julio (2020)
    Many functional analysis tools have been developed to extract functional and mechanistic insight from bulk transcriptome data. With the advent of single-cell RNA sequencing (scRNA-seq), it is in principle possible to do ...
  • ROCplot.org: Validating predictive biomarkers of chemotherapy/hormonal therapy/anti-HER2 therapy using transcriptomic data of 3,104 breast cancer patients 
    Fekete, János Tibor; Győrffy, Balázs (2019)
    Systemic therapy of breast cancer can include chemotherapy, hormonal therapy, and targeted therapy. Prognostic biomarkers are able to predict survival and predictive biomarkers are able to predict therapy response. In this ...
  • Rodent models of complement activation-related pseudoallergy: Inducers, symptoms, inhibitors and reaction mechanisms 
    Dézsi, László; Rosivall, László; Hamar, Péter; Szebeni, János; Szénási, Gábor (2015)
    Complement activation-related pseudoallergy (CARPA) is a hypersensitivity reaction to intravenous administration of nanoparticle-containing medicines (nanomedicines). This review focuses on CARPA in rodent models: rats, ...
  • Role for the Wilms tumor gene in genital development? 
    van Heyningen V; Bickmore WA; Seawright A; Fletcher JM; Maule J; Fekete, György; Gessler M; Bruns GA; Huerre Jeanpierre C; Junien C; Williams B R G; Hastie N D (1990)
  • Role of Altered Expression of miR-146a, miR-155, and miR-122 in Pediatric Patients with Inflammatory Bowel Disease 
    Béres, Nóra; Szabó, Dolóresz; Kocsis, Dorottya; Szucs D; Kiss, Zoltán; Müller, Katalin Eszter; Lendvai, Gábor András; Kiss, András; Arató, András; Sziksz, Erna; Vannay, Ádám; Szabó, Attila; Veres, Gábor (2016)
    BACKGROUND: Evidence suggests the central role of tumor necrosis factor (TNF)-alpha in the pathomechanism of inflammatory bowel disease (IBD); however, its effect on epigenetic factors, including small non-coding microRNAs ...